Mariann Gyöngyösi is an expert in Cardiology at Medical University of Vienna (Austria). As of October 2026, ScienceLeadR ranks Mariann Gyöngyösi in the top 1% of experts worldwide for Myocardial Ischemia. Mariann Gyöngyösi has authored 308 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 1,144 (community average: 125). How the SLR is computed.

LeadR Profile

Mariann Gyöngyösi Medical University of Vienna Austria
1 144 ScienceLeadR Reputation 1144
Network Map

Cardiology

Subspecialties: Biochemistry - Infectiology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026

Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 308

Citations

Citations: 9 757 1st author: 64 Last author: 65 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Routine laboratory data are decoupled from symptom phenotype and prognosis in Long COVID: within-cohort variation is dominated by age.
PMID 42861769 — research design, laboratories, phenotype, cluster analysis, latent class analysis, prognosis, post-acute covid-19 syndrome
Clin Chem Lab Med20260
Delayed intracardiac remote ischemic preconditioning reduces infarct size in remote myocardium of pigs.
PMID 42671614 — genes, cardiovascular system, arteries, myocardium, reperfusion, conditioning, psychological, ischemic preconditioning, ischemia, superoxide dismutase 2
Basic Res Cardiol20260
Beneficial Effect of COVID-19 Vaccination on Decreased Pulmonary Vascular and Airway Volumes of Patients with Long-COVID Syndrome.
PMID 42506382 — lung, blood, vaccines, vaccination, signs and symptoms, covid-19, blood volume, post-acute covid-19 syndrome
Med Sci (Basel)20260
Cardiac Circular RNAs CDR1as, Circ-RCAN2, Circ-C12orf29 Show Cell-Specific Hypoxia-Induced Dysregulation and Distinct In Vitro Effects.
PMID 41226374 — cells, up-regulation, myocardial infarction, micrornas, rna, small interfering, rna, circular, stem cells, hypoxia, therapeutics
Int J Mol Sci20250
Combined Cardiac Arrhythmias Leading to Electrical Chaos Developed in the Convalescent Phase of SARS-CoV-2 Infection: A Case Report and Literature Review.
PMID 40943813 — sars-cov-2, arrhythmias, cardiac, immunoglobulin a, covid-19, myocarditis, therapeutics, severe acute respiratory syndrome-related coronavirus, infections, electrocardiography
J Clin Med20251

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 6
Phase 3 2
Phase 2 1
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 8
Unknown 2
Recruiting 1

By type:

Interventional 7
Observational 4

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 2
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Post COVID 19 Outpatient Care and Biomarkers
NCT05398952 — registries, laboratories, serum, fatigue syndrome, chronic, biomarkers, signs and symptoms, covid-19, myocarditis, fatigue, ambulatory care, outpatients, plasma
N/ARecruiting2021

LeadR Networks

Main global connection map